Welcome to LookChem.com Sign In|Join Free

CAS

  • or

167298-54-6

Post Buying Request

167298-54-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

167298-54-6 Usage

General Description

2-Pyridinemethanamine,6-amino-(9CI) is a chemical compound with the molecular formula C6H8N2. It is a derivative of pyridine and contains an amino group. 2-Pyridinemethanamine,6-amino-(9CI) is commonly used in the synthesis of pharmaceuticals and agrochemicals. It has also been studied for its potential applications in organic synthesis and as a building block in the production of various specialty chemicals. Additionally, 2-Pyridinemethanamine,6-amino-(9CI) has been investigated for its pharmacological properties and potential therapeutic use in the treatment of various medical conditions. Overall, this chemical compound has a wide range of potential applications and is the subject of ongoing research in the fields of chemistry and pharmacology.

Check Digit Verification of cas no

The CAS Registry Mumber 167298-54-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,7,2,9 and 8 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 167298-54:
(8*1)+(7*6)+(6*7)+(5*2)+(4*9)+(3*8)+(2*5)+(1*4)=176
176 % 10 = 6
So 167298-54-6 is a valid CAS Registry Number.

167298-54-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-(Aminomethyl)-2-pyridinamine

1.2 Other means of identification

Product number -
Other names 6-amino-4H,7H-[1,3]dithiino[5,4-d]pyrimidin-8-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:167298-54-6 SDS

167298-54-6Relevant articles and documents

PYRAZINE COMPOUNDS AND USES THEREOF

-

Page/Page column 116; 150-151, (2020/03/05)

The present disclosure novel pyrazine compounds targeting adenosine receptors (especially A1 and A2, particularly A2a). The present disclosure also relates to pharmaceutical compositions comprising one or more of the compounds as an active ingredient, and use of the compounds in the treatment of adenosine receptor (AR) associated diseases, for example cancer such as NSCLC, RCC, prostate cancer, and breast cancer.

Novel pyrrolyl 2-aminopyridines as potent and selective human β-secretase (BACE1) inhibitors

Malamas, Michael S.,Barnes, Keith,Hui, Yu,Johnson, Matthew,Lovering, Frank,Condon, Jeff,Fobare, William,Solvibile, William,Turner, Jim,Hu, Yun,Manas, Eric S.,Fan, Kristi,Olland, Andrea,Chopra, Rajiv,Bard, Jonathan,Pangalos, Menelas N.,Reinhart, Peter,Robichaud, Albert J.

scheme or table, p. 2068 - 2073 (2010/06/19)

The proteolytic enzyme β-secretase (BACE1) plays a central role in the synthesis of the pathogenic β-amyloid in Alzheimer's disease. Recently, we reported small molecule acylguanidines as potent BACE1 inhibitors. However, many of these acylguanidines have a high polar surface area (e.g. as measured by the topological polar surface area or TPSA), which is unfavorable for crossing the blood-brain barrier. Herein, we describe the identification of the 2-aminopyridine moiety as a bioisosteric replacement of the acylguanidine moiety, which resulted in inhibitors with lower TPSA values and superior brain penetration. X-ray crystallographic studies indicated that the 2-aminopyridine moiety interacts directly with the catalytic aspartic acids Asp32 and Asp228 via a hydrogen-bonding network.

PROKINETICIN 2 RECEPTOR ANTAGONISTS

-

Page/Page column 98, (2010/11/28)

The present invention relates to certain novel compounds of Formula (I): and methods for the treatment of prokineticin 2 or prokinetin 2 receptor mediated disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 167298-54-6